题名 | Mycobacterium paragordonae is an emerging pathogen in human pulmonary disease: clinical features, antimicrobial susceptibility testing and outcomes |
作者 | |
通讯作者 | Li,Yanming; Qu,Jiuxin |
发表日期 | 2022
|
DOI | |
发表期刊 | |
EISSN | 2222-1751
|
卷号 | 11期号:1页码:1973-1981 |
摘要 | Objectives: Mycobacterium paragordonae (MPG) is an emerging and less common type of Non-tuberculous mycobacteria (NTM) and we know little about its characteristics and prognosis, hence we constructed this retrospective cohort study. Methods: MPG was identified using MALD-TOF MS, multi-target combined gene sequencing and WGS. Clinical information was collected, antimicrobial susceptibility testing was measured using the SLOMYCO panel, and optimal growth temperature testing was measured using Lowenstein-Jensen medium. Results: Eight MPGs were isolated from 1730 NTMs (0.46%); the mean age of MPG pulmonary disease (MPG-PD) patients was 42.38 ± 9.92 years, 37.5% were male, and the average BMI was 18.4 ± 0.51 kg/m. All patients had the symptoms of cough and sputum and CT images mainly presented in patchy or streaky shadows, MPG grew at 25°C, 30°C and 37°C, and the optimal growth temperature is 37°C. MPGs were sensitive to clarithromycin, rifabutin, amikacin, linezolid, moxifloxacin, cotrimoxazole and ciprofloxacin, two isolates were resistant to rifampicin. Two patients had follow up information, their imaging remained stable during the follow-up. Conclusions: MPG-PD is a rare NTM disease and is more likely to develop in middle-aged, female, and low BMI patients. The patients present with no specific features within the symptoms as well as the CT imaging. The optimal growth temperature of MPG is at 37°C, MPG-PD has excellent sensitivity to drugs recommended by CLSI and presents with a stable disease. |
关键词 | |
相关链接 | [Scopus记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 第一
; 通讯
|
资助项目 | State Key Laboratory of Infectious Disease Prevention and Control[2019SKLID302];Science and Technology Planning Project of Guangdong Province[2020B1111170014];National Natural Science Foundation of China[81870013];
|
WOS研究方向 | Immunology
; Infectious Diseases
; Microbiology
|
WOS类目 | Immunology
; Infectious Diseases
; Microbiology
|
WOS记录号 | WOS:000837484500001
|
出版者 | |
Scopus记录号 | 2-s2.0-85135598972
|
来源库 | Scopus
|
引用统计 |
被引频次[WOS]:6
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/375605 |
专题 | 南方科技大学第二附属医院 |
作者单位 | 1.Department of Clinical Laboratory,National Clinical Research Center for Infectious Diseases,Guangdong Provincial Clinical Research Center for Infectious Diseases (Tuberculosis),Shenzhen Clinical Research Center for Tuberculosis,The Third People's Hospital of Shenzhen,Southern University of Science and Technology,Shenzhen,China 2.Department of Medical Imaging,National Clinical Research Center for Infectious Diseases,Guangdong Provincial Clinical Research Center for Infectious Diseases (Tuberculosis),Shenzhen Clinical Research Center for Tuberculosis,The Third People's Hospital of Shenzhen,Southern University of Science and Technology,Shenzhen,China 3.National Tuberculosis Reference Laboratory,Chinese Center for Disease Control and Prevention,Beijing,China 4.Department of Pulmonary and Critical Care Medicine,National Center of Gerontology,Chinese Academy of Medical Sciences,Beijing Hospital,National Health Commission,Institute of Geriatric Medicine,Beijing,China 5. |
第一作者单位 | 南方科技大学第二附属医院 |
通讯作者单位 | 南方科技大学第二附属医院 |
第一作者的第一单位 | 南方科技大学第二附属医院 |
推荐引用方式 GB/T 7714 |
Li,Yuanchun,Zhang,Wenping,Zhao,Jing,et al. Mycobacterium paragordonae is an emerging pathogen in human pulmonary disease: clinical features, antimicrobial susceptibility testing and outcomes[J]. Emerging Microbes and Infections,2022,11(1):1973-1981.
|
APA |
Li,Yuanchun.,Zhang,Wenping.,Zhao,Jing.,Lai,Wenjie.,Zhao,Yanlin.,...&Qu,Jiuxin.(2022).Mycobacterium paragordonae is an emerging pathogen in human pulmonary disease: clinical features, antimicrobial susceptibility testing and outcomes.Emerging Microbes and Infections,11(1),1973-1981.
|
MLA |
Li,Yuanchun,et al."Mycobacterium paragordonae is an emerging pathogen in human pulmonary disease: clinical features, antimicrobial susceptibility testing and outcomes".Emerging Microbes and Infections 11.1(2022):1973-1981.
|
条目包含的文件 | 条目无相关文件。 |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论